Michael Lisjak - Mar 7, 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Regulatory Officer
Signature
/s/ Michael Lisjak
Stock symbol
CYTH
Transactions as of
Mar 7, 2023
Transactions value $
$0
Form type
4
Date filed
3/9/2023, 04:11 PM
Previous filing
Mar 2, 2022
Next filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Option (Right to buy) Award $0 +41K $0.00 41K Mar 7, 2023 Common Stock 41K $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period in equal monthly installments.